Key facts
- Galderma agreed to acquire ZO Skin Health for $1.5 billion.
Galderma agrees to buy ZO Skin Health for $1.5 billion
IN SHORT
Swiss skincare company Galderma has agreed to acquire ZO Skin Health for approximately $1.5 billion, according to people familiar with the matter. The deal, which could be announced in the coming days, would expand Galderma's presence in the U.S. market. ZO's owner, investment firm Blackstone, had been exploring a sale of the company.
Key Numbers
$1.5 billionGalderma acquisition price for ZO Skin Health
20 yearsZO Skin Health's operating history
2026 or early 2027Expected closing timeframe for the transaction
Who's Involved
Galderma
Swiss skincare firm that agreed to acquire ZO Skin Health
ZO Skin Health
U.S.-based medical-grade skincare company to be acquired
Blackstone
Owner of ZO Skin Health exploring a sale
Zein Obagi
Dermatologist who founded ZO Skin Health in 2007
↳ Why This Matters
The acquisition will expand Galderma's presence in the physician-dispensed skincare market, a fast-growing segment, and integrate ZO Skin Health's product lines into its portfolio.